WO2004001069A3 - Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire - Google Patents
Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire Download PDFInfo
- Publication number
- WO2004001069A3 WO2004001069A3 PCT/FR2003/001910 FR0301910W WO2004001069A3 WO 2004001069 A3 WO2004001069 A3 WO 2004001069A3 FR 0301910 W FR0301910 W FR 0301910W WO 2004001069 A3 WO2004001069 A3 WO 2004001069A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- rtn3
- gene
- compositions
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- General Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003263250A AU2003263250A1 (en) | 2002-06-25 | 2003-06-20 | Compositions and methods for detecting pathologies affecting neuromuscular transmission |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR02/07846 | 2002-06-25 | ||
FR0207846A FR2841261B1 (fr) | 2002-06-25 | 2002-06-25 | Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004001069A2 WO2004001069A2 (fr) | 2003-12-31 |
WO2004001069A3 true WO2004001069A3 (fr) | 2004-04-08 |
Family
ID=29720017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2003/001910 WO2004001069A2 (fr) | 2002-06-25 | 2003-06-20 | Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003263250A1 (fr) |
FR (1) | FR2841261B1 (fr) |
WO (1) | WO2004001069A2 (fr) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998039448A2 (fr) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 nouvelles proteines secretees |
WO1999031236A2 (fr) * | 1997-12-17 | 1999-06-24 | Genset | ADNc PROLONGES POUR PROTEINES SECRETEES |
EP1067182A2 (fr) * | 1999-07-08 | 2001-01-10 | Helix Research Institute | Proteine secretoire ou proteine de membrane |
WO2001036631A1 (fr) * | 1999-11-15 | 2001-05-25 | Smithkline Beecham P.L.C. | Polynucleotides et polypeptides humains nogo-c et leurs utilisations |
US6277974B1 (en) * | 1999-12-14 | 2001-08-21 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
WO2001075067A2 (fr) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
US20020012965A1 (en) * | 2000-01-12 | 2002-01-31 | Strittmatter Stephen M. | Nogo receptor-mediated blockade of axonal growth |
-
2002
- 2002-06-25 FR FR0207846A patent/FR2841261B1/fr not_active Expired - Fee Related
-
2003
- 2003-06-20 WO PCT/FR2003/001910 patent/WO2004001069A2/fr not_active Application Discontinuation
- 2003-06-20 AU AU2003263250A patent/AU2003263250A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998039448A2 (fr) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 nouvelles proteines secretees |
WO1999031236A2 (fr) * | 1997-12-17 | 1999-06-24 | Genset | ADNc PROLONGES POUR PROTEINES SECRETEES |
EP1067182A2 (fr) * | 1999-07-08 | 2001-01-10 | Helix Research Institute | Proteine secretoire ou proteine de membrane |
WO2001036631A1 (fr) * | 1999-11-15 | 2001-05-25 | Smithkline Beecham P.L.C. | Polynucleotides et polypeptides humains nogo-c et leurs utilisations |
US6277974B1 (en) * | 1999-12-14 | 2001-08-21 | Cogent Neuroscience, Inc. | Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
US20020012965A1 (en) * | 2000-01-12 | 2002-01-31 | Strittmatter Stephen M. | Nogo receptor-mediated blockade of axonal growth |
WO2001075067A2 (fr) * | 2000-03-31 | 2001-10-11 | Hyseq, Inc. | Nouveaux acides nucleiques et polypeptides |
Non-Patent Citations (10)
Title |
---|
DATABASE EMBL [online] 13 February 2001 (2001-02-13), DRMANAC RT ET AL: "New isolated polynucleotide and encoded polypeptides, useful in diagnostics, forensics, gene mapping, identification of mutations responsible for genetic disorders or other traits and to assess biodiversity", XP002265566, retrieved from EBI Database accession no. ABG29352 * |
DATABASE EMBL [online] 13 February 2002 (2002-02-13), DRMANAC RT ET AL: "DNA encoding novel human diagnostic protein #29343", XP002265568, retrieved from EBI Database accession no. AAS93539 * |
DATABASE EMBL [online] 13 September 1999 (1999-09-13), BOUGUELERET L ET AL: "New isolated human secreted proteins", XP002265565, retrieved from EBI Database accession no. AAY35980 * |
DATABASE EMBL [online] 13 September 1999 (1999-09-13), BOUGUELERET L ET AL: "New isolated human secreted proteins", XP002265570, retrieved from EBI Database accession no. AAX97644 * |
DATABASE EMBL [online] 22 January 2000 (2000-01-22), HATTORI M ET AL: "Homo sapiens 151,639 genomic DNA of 11q13", XP002265571, retrieved from EBI Database accession no. AP001193 * |
DATABASE EMBL [online] 25 January 1999 (1999-01-25), "Human secreted protein encoded by gene 92 clone HAUBL57", XP002265569, retrieved from EBI Database accession no. AAW74963 * |
DATABASE EMBL [online] 27 November 1999 (1999-11-27), HATTORI M ET AL: "Homosapiens genomic DNA", XP002265572, retrieved from EBI Database accession no. AP000753 * |
DATABASE EMBL [online] 30 May 2001 (2001-05-30), OTA T ET AL: "Secretory protein or membrane protein", XP002265567, retrieved from EMI Database accession no. AX136396 * |
IWAHASHI J ET AL: "Caenorhabditis elegans reticulon interacts with RME-1 during embryogenesis", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 293, May 2002 (2002-05-01), pages 698 - 704, XP002233930 * |
MOREIRA E ET AL: "Cloning of a novel member of the reticulon gene family (RTN3): Gene structure and chromosal localization to 11q13", GENOMICS, vol. 58, 1999, pages 73 - 81, XP002233929 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003263250A1 (en) | 2004-01-06 |
WO2004001069A2 (fr) | 2003-12-31 |
FR2841261A1 (fr) | 2003-12-26 |
AU2003263250A8 (en) | 2004-01-06 |
FR2841261B1 (fr) | 2004-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1063423A1 (en) | Methods to diagnose treat and prevent bone loss | |
WO2006090389A3 (fr) | Nouveaux marqueurs diagnostiques, en particulier pour l'imagerie in vivo, et dosage et procedes d'utilisation associes | |
WO2002040634A3 (fr) | Minireseaux d'expression et leurs utilisations | |
WO2006014628A8 (fr) | Procédés d’évaluation des risques de développement de maladies cardio-vasculaires | |
WO2005114190A3 (fr) | Procedes pour identifier des marqueurs biologiques | |
EP1547996A4 (fr) | Sondes de diagnostic et remedes contre des maladies presentant une accumulation de la proteine du prion et methode de marquage | |
WO2003069332A3 (fr) | Detection et/ou surveillance de maladies liees a la synucleine | |
AU2002327308A1 (en) | Methods for evaluating pathologic conditions using extracellular rna | |
WO2004065576A3 (fr) | Methodes et compositions de traitement de troubles urologiques a l'aide de genes 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579, 15985, 15625, 760, 18603, | |
WO2004067570A3 (fr) | Diagnostic et traitement du cancer de la prostate | |
WO2008055491A3 (fr) | Diagnostic et stratification des risques de diabète sucré par mr-proadm | |
WO2004046729A3 (fr) | Marqueurs a base de fluide corporel pour l'hypoxie tissulaire | |
SG171691A1 (en) | Biomarkers for diagnosing multiple sclerosis, and methods thereof | |
ATE384519T1 (de) | Hemmer-darstellende mittel | |
WO2007146668A3 (fr) | Utilisation d'imp3 en tant que marqueur pronostique de cancer | |
DE69940465D1 (de) | Verfahren zum nachweis und hemmung der angiogenese | |
WO2003046578A3 (fr) | Méthode pour estimer et faire un pronostic sur la sarcoidose | |
DE60137264D1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
ATE415632T1 (de) | Verfahren zur diagnose und behandlung von morbus crohn | |
DE602004024549D1 (de) | Diagnose und überwachung von hepatozellulärem karzinom | |
WO2006046270A3 (fr) | Mutants de proteine nucleophosmine (npm), sequences geniques correspondantes et utilisations de ceux-ci | |
WO2005124358A3 (fr) | Diagnostic et traitement de maladies associees a siglec-6 | |
WO2004100998A3 (fr) | Compositions et procedes de visualisation non effractive du beta-amyloide soluble | |
WO2010033951A3 (fr) | Procédé d'identification et de prédiction de la sclérose en plaques et de la réponse à la thérapie | |
WO2008027379A3 (fr) | Indicateurs d'activité sirtuine et procédés d'utilisation de ceux-ci |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |